These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10676575)

  • 1. Second-generation perfluorocarbon emulsion blood substitutes.
    Lowe KC
    Artif Cells Blood Substit Immobil Biotechnol; 2000 Jan; 28(1):25-38. PubMed ID: 10676575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a novel perfluorocarbon emulsion on neutrophil chemiluminescence in human whole blood in vitro.
    Edwards CM; Lowe KC; Röhlke W; Geister U; Reuter P; Meinert H
    Artif Cells Blood Substit Immobil Biotechnol; 1997 May; 25(3):255-60. PubMed ID: 9167840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel fluorinated surfactants for perfluorochemical emulsification: biocompatibility assessments of glycosidic and polyol derivatives.
    Edwards CM; Lowe KC; Trabelsi H; Lucas P; Cambon A
    Artif Cells Blood Substit Immobil Biotechnol; 1997 May; 25(3):327-33. PubMed ID: 9167847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxygen solubility, rheology and hemodynamics of perfluorocarbon emulsion blood substitutes.
    Millard RW
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(2):235-44. PubMed ID: 8087245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorocarbon emulsions--the stability issue.
    Postel M; Riess JG; Weers JG
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):991-1005. PubMed ID: 7849970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a high concentration perfluorocarbon emulsion on platelet function.
    Smith DJ; Lane TA
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):1045-9. PubMed ID: 1391425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perfluorocarbon-based oxygen delivery.
    Riess JG
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):567-80. PubMed ID: 17090429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake of concentrated perfluorocarbon emulsions into rat lymphoid tissues.
    Bentley PK; Johnson OL; Washington C; Lowe KC
    J Pharm Pharmacol; 1993 Mar; 45(3):182-5. PubMed ID: 8097775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the perfluorocarbon emulsions of second generation.
    Meinert H; Fackler R; Knoblich A; Mader J; Reuter P; Röhlke W
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):805-18. PubMed ID: 1391515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro comparison of dodecafluoropentane (DDFP), perfluorodecalin (PFD), and perfluoroctylbromide (PFOB) in the facilitation of oxygen exchange.
    Johnson JL; Dolezal MC; Kerschen A; Matsunaga TO; Unger EC
    Artif Cells Blood Substit Immobil Biotechnol; 2009; 37(4):156-62. PubMed ID: 19548131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfluorocarbon-based oxygen carriers: from physics to physiology.
    Jägers J; Wrobeln A; Ferenz KB
    Pflugers Arch; 2021 Feb; 473(2):139-150. PubMed ID: 33141239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of newly developed perfluorocarbon emulsion: oxygen carrying capacity as the blood substitute in vivo.
    Sakanoue J; Tamura M; Fukushima S; Takeuchi Y; Sakuma I; Kitabatake A
    Artif Cells Blood Substit Immobil Biotechnol; 2001 Sep; 29(5):389-97. PubMed ID: 11708662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A stable perfluorochemical blood substitute.
    Mukherji B; Sloviter HA
    Transfusion; 1991 May; 31(4):324-6. PubMed ID: 2020995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of semifluorinated alkanes in blood-substitutes.
    Meinert H; Knoblich A
    Biomater Artif Cells Immobilization Biotechnol; 1993; 21(5):583-95. PubMed ID: 8117848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The initial response of blood leukocytes to incubation with perfluorocarbon blood substitute emulsions.
    McDonagh PF; Wilson DS
    Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(3):439-47. PubMed ID: 7493065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The elimination peculiarities of perfluorocarbon emulsions stabilized with egg yolk phospholipid.
    Putyatina TK; Aprosin UD; Afonin NI
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1281-5. PubMed ID: 7849934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perfluorodecalin emulsion tested for biocompatibility in macrophages by means of a magnetometric method.
    Koester M; Lutz J; Augustin AJ; Meinert H
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1231-6. PubMed ID: 7849927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Perfluorocarbon emulsions and other corpuscular systems influence on neutrophil activity].
    Shekhtman DG; Safronova VG; Sklifas AN; Alovskaia AA; Gapeev AB; Obraztsov VV; Chemeris NK
    Biofizika; 1997; 42(6):1260-6. PubMed ID: 9490112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative assessment of phospholipid-stabilized perfluorocarbon-based blood substitutes.
    Tarara TE; Malinoff SH; Pelura TJ
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1287-93. PubMed ID: 7849935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of high concentration perflubron emulsion on platelet function.
    Smith DJ; Lane TA
    Biomater Artif Cells Immobilization Biotechnol; 1993; 21(2):173-81. PubMed ID: 8318610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.